TELA Bio (TELA) Liabilities and Shareholders Equity (2018 - 2026)
TELA Bio (TELA) posted quarterly Liabilities and Shareholders Equity of $69.9 million for Q1 2026, down 9.53% year-over-year from $77.3 million in Q1 2025, and down 14.16% quarter-over-quarter from $81.4 million in Q4 2025.
TELA Bio (TELA) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends
TELA Bio's Liabilities and Shareholders Equity history runs 9 years deep, the most recent figure standing at $69.9 million for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity fell 9.53% year-over-year to $69.9 million; the TTM figure through Mar 2026 stood at $280.4 million (up 1.22% YoY), while the FY2025 annual figure was $81.4 million, down 5.95% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $69.9 million, down from $81.4 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $94.4 million in Q2 2023, with the low at $51.3 million in Q2 2022.
- The 5-year median for Liabilities and Shareholders Equity is $69.9 million (2026), against an average of $70.7 million.
- The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity surged 83.87% in 2023, then sank 39.28% in 2024.
- TELA Bio's Liabilities and Shareholders Equity stood at $67.9 million in 2022, then grew by 15.02% to $78.0 million in 2023, then rose by 10.92% to $86.6 million in 2024, then retreated by 5.95% to $81.4 million in 2025, then retreated by 14.16% to $69.9 million in 2026.
- Business Quant data shows TELA's Liabilities and Shareholders Equity at $69.9 million in Q1 2026, $81.4 million in Q4 2025, and $61.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 10.74 Bn |
| 10 | TELA Bio | 37.05 Mn | 6.63 Mn | 13.94 Mn | 59.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.74 Mn |
| Mar 31, 2026 | 69.89 Mn |
| Dec 31, 2025 | 81.42 Mn |
| Sep 30, 2025 | 61.59 Mn |
| Jun 30, 2025 | 67.54 Mn |
| Mar 31, 2025 | 77.25 Mn |
| Dec 31, 2024 | 86.57 Mn |
| Sep 30, 2024 | 53.02 Mn |
| Jun 30, 2024 | 60.20 Mn |
| Mar 31, 2024 | 71.84 Mn |
| Dec 31, 2023 | 78.05 Mn |
| Sep 30, 2023 | 87.32 Mn |
| Jun 30, 2023 | 94.39 Mn |
| Mar 31, 2023 | 58.79 Mn |
| Dec 31, 2022 | 67.86 Mn |
| Sep 30, 2022 | 79.56 Mn |
| Jun 30, 2022 | 51.33 Mn |
| Mar 31, 2022 | 55.36 Mn |
| Dec 31, 2021 | 62.54 Mn |
| Sep 30, 2021 | 68.81 Mn |